HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid productsAugust 1, 2020
Quarterly pharmacy formulary change notice
The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) members.
Effective July 1, 2020, formulary changes, non-formulary changes and prior authorization requirements will apply.
Effective for all members on July 1, 2020 |
|||
Therapeutic class |
Medication |
Formulary status change |
Potential alternatives (preferred products) |
ADHD AGENTS |
DYANAVEL XR 2.5 MG/ML SUSPENSION |
NON-PREFERRED |
Vyvanse capsules/chewable tablet Adderall XR capsules Dextroamphetamine tablet |
ADHD AGENTS |
QUILLIVANT XR 25 MG/5 ML SUSPENSION QUILLICHEW ER 40 MG CHEW TABLET QUILLICHEW ER 20 MG CHEW TABLET QUILLICHEW ER 30 MG CHEW TABLET |
NON-PREFERRED |
Focalin XR capsules Daytrana transdermal patch Concerta tablet methylphenidate IR capsules/tablet |
ANDROGENS |
ANDROGEL 1.62%(1.25G) |
NON-PREFERRED WITH PA |
testosterone pump (genric androgel) PA required |
ANTIDIABETIC COMBINATIONS |
INVOKAMET 50-500 MG TABLET INVOKAMET 50-1,000 MG TABLET INVOKAMET 150-500 MG TABLET INVOKAMET 150-1,000 MG TABLET XIGDUO XR 2.5 MG-1,000 MG TAB XIGDUO XR 5 MG-500 MG TABLET XIGDUO XR 5 MG-1,000 MG TABLET XIGDUO XR 10 MG-500 MG TABLET XIGDUO XR 10 MG-1,000 MG TAB |
PREFERRED WITH MIN AGE LIMIT OF 18 YEARS AND OLDER |
N/A |
INSULIN |
HUMALOG JR HUMALOG MIX 50/50 HUMALOG 100/ML VIAL |
PREFERRED |
N/A |
INSULIN |
INSULIN LISPRO KWIKPEN ADMELOG SOLOSTAR |
NON-PREFERRED |
HUMALOG KWIK INJ 100/ML |
INSULIN |
NOVOLIN N FLEXPEN |
NON-PREFERRED |
HUMULIN N KWIKPEN |
INSULIN |
NOVOLIN 70/30 FLEXPEN |
NON-PREFERRED |
HUMULIN 70/30 KWIKPEN |
URINARY ANTISPASMODICS |
SOLIFENACIN 5 MG TABLET SOLIFENACIN 10 MG TABLET |
PREFERRED |
N/A |
URINARY ANTISPASMODICS |
VESICARE 5 MG TABLET VESICARE 10 MG TABLET |
NON-PREFERRED |
SOLIFENACIN 5 MG TABLET SOLIFENACIN 10 MG TABLET |
Edits effective July 1, 2020 No changes in preferred/nonpreferred status revision or addition to UM edit only |
||
Therapeutic class |
Medication |
Formulary status change |
ALLERGENIC EXTRACTS |
PALFORZIA CAPSULES |
PA REQUIRED |
ANALGESICS - ANTI-INFLAMMATORY |
OLUMIANT 1 MG TABLET OLUMIANT 2 MG TABLET |
ADD QTY LIMIT 30 PER 30 DAYS |
ANALGESICS - ANTI-INFLAMMATORY |
OTEZLA 30 MG TABLET |
ADD QTY LIMIT 60 PER 30 DAYS |
ANTIRHEUMATIC ANTIMETABOLITES |
OTREXUP INJECTIONS RASUVO INJECTIONS |
ADD QTY LIMIT 4 PER 28 DAYS |
HISTAMINE H3-RECEPTOR ANTAGONIST/INVERSE AGONISTS |
WAKIX 4.45MG TABLET WAKIX 17.8MG TABLET |
PA REQUIRED |
INTERLEUKIN-1 RECEPTOR ANTAGONIST |
KINERET INJ |
ADD QTY LIMIT 30 PER 30 DAYS |
MIGRAINE PRODUCTS |
REYVOW TABLET UBRELVY TABLET |
PA REQUIRED |
What action do I need to take?
Please review these changes and work with your Anthem HealthKeepers Plus and/or Anthem CCC Plus patients to transition them to formulary alternatives. If you determine formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization to continue coverage beyond the applicable effective date.
What if I need assistance?
We recognize the unique aspects of patients’ cases. If your patients cannot be converted to a formulary alternative, call our Pharmacy department at 1-800-901-0020 (Anthem HealthKeepers Plus members) or 1-855-323-4687 (Anthem CCC Plus members) and follow the voice prompts for pharmacy prior authorization. You can find the Preferred Drug List (formulary) on our provider website at https://mediproviders.anthem.com/va > Pharmacy > Medicaid Common Core Formulary > Common Core Preferred Drug List.
If you have any questions about this communication, call our Provider Services at 1‑800‑901‑0020 or Anthem CCC Plus Provider Services at 1‑855‑323‑4687.
AVA-NU-0266-20
PUBLICATIONS: August 2020 Anthem Provider News - Virginia
To view this article online:
Visit https://providernews.anthem.com/virginia/articles/quarterly-pharmacy-formulary-change-notice-5-5478
Or scan this QR code with your phone